Contribution of Dysregulated DNA Methylation to Autoimmunity
Epigenetic mechanisms, such as DNA methylation, histone modifications, and non-coding RNAs are known regulators of gene expression and genomic stability in cell growth, development, and differentiation. Because epigenetic mechanisms can regulate several immune system elements, epigenetic alterations...
Guardado en:
Autores principales: | , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/b5a17a3ac5a947c3b0c7a432aa2ac972 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:b5a17a3ac5a947c3b0c7a432aa2ac972 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:b5a17a3ac5a947c3b0c7a432aa2ac9722021-11-11T17:19:22ZContribution of Dysregulated DNA Methylation to Autoimmunity10.3390/ijms2221118921422-00671661-6596https://doaj.org/article/b5a17a3ac5a947c3b0c7a432aa2ac9722021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11892https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067Epigenetic mechanisms, such as DNA methylation, histone modifications, and non-coding RNAs are known regulators of gene expression and genomic stability in cell growth, development, and differentiation. Because epigenetic mechanisms can regulate several immune system elements, epigenetic alterations have been found in several autoimmune diseases. The purpose of this review is to discuss the epigenetic modifications, mainly DNA methylation, involved in autoimmune diseases in which T cells play a significant role. For example, Rheumatoid Arthritis and Systemic Lupus Erythematosus display differential gene methylation, mostly hypomethylated 5′-C-phosphate-G-3′ (CpG) sites that may associate with disease activity. However, a clear association between DNA methylation, gene expression, and disease pathogenesis must be demonstrated. A better understanding of the impact of epigenetic modifications on the onset of autoimmunity will contribute to the design of novel therapeutic approaches for these diseases.Samanta C. FunesAyleen Fernández-FierroDiego Rebolledo-ZeladaJuan P. Mackern-ObertiAlexis M. KalergisMDPI AGarticleDNA methylationepigeneticsystemic autoimmunityrheumatoid arthritisCpGBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11892, p 11892 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
DNA methylation epigenetic systemic autoimmunity rheumatoid arthritis CpG Biology (General) QH301-705.5 Chemistry QD1-999 |
spellingShingle |
DNA methylation epigenetic systemic autoimmunity rheumatoid arthritis CpG Biology (General) QH301-705.5 Chemistry QD1-999 Samanta C. Funes Ayleen Fernández-Fierro Diego Rebolledo-Zelada Juan P. Mackern-Oberti Alexis M. Kalergis Contribution of Dysregulated DNA Methylation to Autoimmunity |
description |
Epigenetic mechanisms, such as DNA methylation, histone modifications, and non-coding RNAs are known regulators of gene expression and genomic stability in cell growth, development, and differentiation. Because epigenetic mechanisms can regulate several immune system elements, epigenetic alterations have been found in several autoimmune diseases. The purpose of this review is to discuss the epigenetic modifications, mainly DNA methylation, involved in autoimmune diseases in which T cells play a significant role. For example, Rheumatoid Arthritis and Systemic Lupus Erythematosus display differential gene methylation, mostly hypomethylated 5′-C-phosphate-G-3′ (CpG) sites that may associate with disease activity. However, a clear association between DNA methylation, gene expression, and disease pathogenesis must be demonstrated. A better understanding of the impact of epigenetic modifications on the onset of autoimmunity will contribute to the design of novel therapeutic approaches for these diseases. |
format |
article |
author |
Samanta C. Funes Ayleen Fernández-Fierro Diego Rebolledo-Zelada Juan P. Mackern-Oberti Alexis M. Kalergis |
author_facet |
Samanta C. Funes Ayleen Fernández-Fierro Diego Rebolledo-Zelada Juan P. Mackern-Oberti Alexis M. Kalergis |
author_sort |
Samanta C. Funes |
title |
Contribution of Dysregulated DNA Methylation to Autoimmunity |
title_short |
Contribution of Dysregulated DNA Methylation to Autoimmunity |
title_full |
Contribution of Dysregulated DNA Methylation to Autoimmunity |
title_fullStr |
Contribution of Dysregulated DNA Methylation to Autoimmunity |
title_full_unstemmed |
Contribution of Dysregulated DNA Methylation to Autoimmunity |
title_sort |
contribution of dysregulated dna methylation to autoimmunity |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/b5a17a3ac5a947c3b0c7a432aa2ac972 |
work_keys_str_mv |
AT samantacfunes contributionofdysregulateddnamethylationtoautoimmunity AT ayleenfernandezfierro contributionofdysregulateddnamethylationtoautoimmunity AT diegorebolledozelada contributionofdysregulateddnamethylationtoautoimmunity AT juanpmackernoberti contributionofdysregulateddnamethylationtoautoimmunity AT alexismkalergis contributionofdysregulateddnamethylationtoautoimmunity |
_version_ |
1718432140602900480 |